Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-157079
Filing Date
2025-07-09
Accepted
2025-07-09 16:04:02
Documents
7
Effectiveness Date
2025-07-09

Document Format Files

Seq Description Document Type Size
1 S-8 d31790ds8.htm S-8 43453
2 EX-5.1 d31790dex51.htm EX-5.1 9728
3 EX-23.2 d31790dex232.htm EX-23.2 2570
4 EX-99.1 d31790dex991.htm EX-99.1 202512
5 EX-FILING FEES d31790dexfilingfees.htm EX-FILING FEES 13676
6 GRAPHIC g31790g67b68.jpg GRAPHIC 3009
7 GRAPHIC g31790g78p63.jpg GRAPHIC 10622
  Complete submission text file 0001193125-25-157079.txt   292109
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288584 | Film No.: 251113636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)